Literature DB >> 12865972

Inhibition of smooth muscle contraction by magnolol and honokiol in porcine trachea.

Chien-Hsin Ko1, Hwei-Hsien Chen, Yi-Ruu Lin, Ming-Huan Chan.   

Abstract

Magnolol and honokiol are the two major phenolic constituents of the plant medicine "Houpo" ( Magnolia obovata), which is used in the treatment of chest tightness and asthma. The aim of this study was to investigate the influence of magnolol and honokiol on smooth muscle tone in porcine trachea. Magnolol and honokiol (0.1 - 100 microM) inhibited carbachol- and high K +-induced muscle contractions in a concentration-dependent fashion, but did not affect basal muscle tension. After washout of these pretreatments, carbachol- and high K +-evoked muscle contractions were still abolished, suggesting that the inhibition was irreversible. Magnolol and honokiol also concentration-dependently decreased the Ca 2+-dependent muscle contraction induced by high K + depolarization. Ca 2+ channel antagonists attenuated carbachol-induced muscular response by approximately 30 %, but did not further potentiate the inhibitory actions of magnolol and honokiol on muscle contraction. However, the inhibitory effects of magnolol and honokiol on carbachol-evoked muscular contractile response were partially reversed after removal of Ca 2+ channel antagonist pretreatment. Alternatively, caffeine-elicited muscle contractions were not altered by magnolol, honokiol, and verapamil. In conclusion, the relaxant effects of magnolol and honokiol on porcine tracheal smooth muscle suggest an association with the blockade of Ca 2+ influx through voltage-operated Ca 2+ channels instead of Ca 2+ release from intracellular Ca 2+ stores. The magnolol- and honokiol-induced inhibitions on tracheal smooth muscle contraction may be relevant to the claimed therapeutic effects of the extract from magnolia bark and contribute to their pharmacological effects by acting as anti-asthmatic agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12865972     DOI: 10.1055/s-2003-40654

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  13 in total

1.  Inhibitory Effects of Honokiol on the Voltage-Gated Potassium Channels in Freshly Isolated Mouse Dorsal Root Ganglion Neurons.

Authors:  Anqi Sheng; Yan Zhang; Guang Li; Guangqin Zhang
Journal:  Neurochem Res       Date:  2017-11-24       Impact factor: 3.996

Review 2.  Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents.

Authors:  Mélanie Poivre; Pierre Duez
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

3.  Distinct photoacidity of honokiol from magnolol.

Authors:  Hongmei Li; Xianfeng Wang; Yuzhu Hu
Journal:  J Fluoresc       Date:  2010-09-01       Impact factor: 2.217

4.  The mechanism of honokiol-induced and magnolol-induced inhibition on muscle contraction and Ca2+ mobilization in rat uterus.

Authors:  Yu-Cheng Lu; Hwei-Hsien Chen; Chien-Hsin Ko; Yi-Ruu Lin; Ming-Huan Chan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-18       Impact factor: 3.000

Review 5.  Honokiol, a multifunctional antiangiogenic and antitumor agent.

Authors:  Levi E Fried; Jack L Arbiser
Journal:  Antioxid Redox Signal       Date:  2009-05       Impact factor: 8.401

6.  Honokiol blocks store operated calcium entry in CHO cells expressing the M3 muscarinic receptor: honokiol and muscarinic signaling.

Authors:  Hsiu-Jen Wang; Alexis G Martin; Po-Kuan Chao; Rhett A Reichard; Adam L Martin; Yue-wern Huang; Ming-Huan Chan; Robert S Aronstam
Journal:  J Biomed Sci       Date:  2013-02-23       Impact factor: 8.410

7.  Honokiol, a constituent of Magnolia species, inhibits adrenergic contraction of human prostate strips and induces stromal cell death.

Authors:  Daniel Herrmann; Andrea Schreiber; Anna Ciotkowska; Frank Strittmatter; Raphaela Waidelich; Christian G Stief; Christian Gratzke; Martin Hennenberg
Journal:  Prostate Int       Date:  2014-08-26

8.  In vitro inhibitory activities of magnolol against Candida spp.

Authors:  Peiru Zhou; Jingya Fu; Hong Hua; Xiaosong Liu
Journal:  Drug Des Devel Ther       Date:  2017-09-06       Impact factor: 4.162

9.  Cardiovascular protection of magnolol: cell-type specificity and dose-related effects.

Authors:  Jennifer Hui-Chun Ho; Chuang-Ye Hong
Journal:  J Biomed Sci       Date:  2012-07-31       Impact factor: 8.410

Review 10.  Neuro-modulating effects of honokiol: a review.

Authors:  Anna Woodbury; Shan Ping Yu; Ling Wei; Paul García
Journal:  Front Neurol       Date:  2013-09-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.